Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Dec;27(12):7062-7074.
doi: 10.1111/dom.70105. Epub 2025 Sep 8.

Efficacy and safety of survodutide on glycemic control and weight loss in adults: A systematic review and meta-analysis

Ya-Jun Xiao  1   2 , Shan Yu  3   4 , Yan-Ling Zhang  5   6 , Jiao Chen  7 , Yan-Qun Liu  2 , Xiao-Ling Liu  1 , Chang-Feng Sun  1 , Cun-Liang Deng  1
Affiliations
Meta-Analysis

Efficacy and safety of survodutide on glycemic control and weight loss in adults: A systematic review and meta-analysis

Ya-Jun Xiao et al. Diabetes Obes Metab. 2025 Dec.

Abstract

Aim: This meta-analysis aimed to evaluate the efficacy and safety of survodutide on glycemic control and weight loss in adults.

Methods: We systematically searched PubMed, Embase, the Cochrane Library, Scopus, Web of Science, and ClinicalTrials.gov for randomized controlled trials (RCTs) evaluating the efficacy and safety of survodutide up to 12 July 2025. The primary outcomes were changes in glycated haemoglobin (HbA1c), fasting glucagon levels, body weight, waist circumference, along with the incidence of adverse events (AEs). Secondary outcomes included body mass index (BMI), lipid profiles, and blood pressure.

Results: Six RCTs involving 1272 participants were included in this meta-analysis. Compared with placebo, survodutide significantly reduced HbA1c (weighted mean difference [WMD]: -0.66%, 95% confidence interval [CI] [-1.08, -0.23], p = 0.002) and fasting glucagon levels (WMD: -7 pmol/L, 95% CI [-10.3, -3.69], p = 0.016). Greater reductions were observed in the subgroup receiving a total weekly dose of >2.4 mg compared with the subgroup receiving ≤2.4 mg weekly. Survodutide also significantly decreased body weight (WMD: -6.7 kg, 95% CI [-10.0, -3.4], p < 0.001) and waist circumference (WMD: -7.09 cm, 95% CI [-9.44, -4.47], p < 0.001), with enhanced effects observed at higher total weekly doses (>2.4 mg) and longer treatment durations (>16 weeks). Additionally, significant reductions were observed in BMI, and modest reductions were noted in total cholesterol, triglycerides, and blood pressure. However, survodutide was associated with a higher risk of treatment discontinuation due to AEs, with gastrointestinal AEs being the most common, although there was no significant increase in the incidence of serious AEs.

Conclusions: Survodutide significantly reduced HbA1c, body weight, and waist circumference. A greater reduction in HbA1c was specifically associated with a higher total weekly dose (>2.4 mg), while more pronounced effects on body weight and waist circumference were observed with both higher doses and longer treatment durations (>16 weeks). However, it is crucial to highlight the significant increase in gastrointestinal AEs and the associated risk of treatment discontinuation. Further large-scale, multicentre, long-term, and high-quality RCTs are necessary to validate these results in diverse populations.

Keywords: Survodutide; glycemic control; meta‐analysis; weight loss.

PubMed Disclaimer

References

REFERENCES

    1. Pahlavani N, Malekahmadi M, Sedaghat A, et al. Effects of melatonin and propolis supplementation on inflammation, oxidative stress, and clinical outcomes in patients with primary Pneumosepsis: a randomized controlled clinical trial. Complement Med Res. 2022;29(4):275‐285.
    1. Firouzi S, Pahlavani N, Navashenaq JG, Clayton ZS, Beigmohammadi MT, Malekahmadi M. The effect of vitamin C and Zn supplementation on the immune system and clinical outcomes in COVID‐19 patients. Clin Nutr Open Sci. 2022;44:144‐154.
    1. Malekahmadi M, Shadnoush M, Islam SMS, et al. The effect of French maritime pine bark extract supplementation on inflammation, nutritional and clinical status in critically ill patients with traumatic brain injury: a randomized controlled trial. Phytother Res. 2021;35(9):5178‐5188.
    1. GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402(10397):203‐234.
    1. GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the global burden of disease study 2021. Lancet. 2025;405(10481):813‐838.

MeSH terms